Skip to main content
OIDA Image Collection
Filters:
Reset 
An advertisement for Exalgo. The advertisement is divided into two sections. The top section has a title reading "For your opioid-tolerant chronic pain patients: Consider Rotation to EXALGO as a Logical Choice". Additional text reads "Due to intolerable side effects of oxycodone Elaine might benefit from a dissimilar molecule like hydromorphone. She has already been exposed to oxymorphone an active metabolite of OxyContin (oxycodone)." It features an image of a smiling woman in an orange shirt taking off a mask. The mask is of her own face showing an expression of pain. The Exalgo logo is also featured. <br /><br />The bottom section of the advertisement has information about the medication including its potential risks potential for life-threatening respiratory depression and accidental exposure.

Description

An advertisement for Exalgo. The advertisement is divided into two sections. The top section has a title reading "For your opioid-tolerant chronic pain patients: Consider Rotation to EXALGO as a Logical Choice". Additional text reads "Due to intolerable side effects of oxycodone Elaine might benefit from a dissimilar molecule like hydromorphone. She has already been exposed to oxymorphone an active metabolite of OxyContin (oxycodone)." It features an image of a smiling woman in an orange shirt taking off a mask. The mask is of her own face showing an expression of pain. The Exalgo logo is also featured.

The bottom section of the advertisement has information about the medication including its potential risks potential for life-threatening respiratory depression and accidental exposure.

We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.

Information copied to your clipboard:

"An advertisement for Exalgo. The advertisement is divided into two sections. The top section has a title reading "For your opioid-tolerant chron...